We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

12 hedge funds and large institutions have $607K invested in Achieve Life Sciences in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0% more ownership

Funds ownership: 0.02% → 0.02% (+0%)

20% less funds holding

Funds holding: 15 → 12 (-3)

24% less capital invested

Capital invested by funds: $797K → $607K (-$190K)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$103K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$58.2K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$18.2K
4
PAM
Panagora Asset Management
Massachusetts
+$2.88K
5
BlackRock
BlackRock
New York
+$1.6K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$34K
2
TSS
Two Sigma Securities
New York
-$29K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$27K
4
Citadel Advisors
Citadel Advisors
Florida
-$22K
5
UBS Group
UBS Group
Switzerland
-$3.52K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$219K +$103K +323 +66%
Vanguard Group
2
Vanguard Group
Pennsylvania
$183K +$58.2K +182 +37%
BlackRock
3
BlackRock
New York
$112K +$1.6K +5 +1%
PAM
4
Panagora Asset Management
Massachusetts
$74K +$2.88K +9 +3%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$15K +$18.2K +57 New
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.1K – – –
UBS Group
7
UBS Group
Switzerland
$1K -$3.52K -11 -85%
Citigroup
8
Citigroup
New York
$1K – – –
Fifth Third Bancorp
9
Fifth Third Bancorp
Ohio
$1K +$1.6K +5 New
APA
10
American Portfolios Advisors
New York
$1 – – –
VF
11
Virtu Financial
New York
– -$34K -83 Closed
TSS
12
Two Sigma Securities
New York
– -$29K -72 Closed
Geode Capital Management
13
Geode Capital Management
Massachusetts
– -$27K -67 Closed
Citadel Advisors
14
Citadel Advisors
Florida
– -$22K -55 Closed
Group One Trading
15
Group One Trading
Illinois
– -$1K -2 Closed
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
– -$320 -1 -50%
BDWM
17
Brewin Dolphin Wealth Management
Ireland
– -$18 – –

ACHV Hedge Fund Activity: Q4 2017 in Review

12 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2017, worth a combined $607K — down 24% from $797K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ACHV and 2 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $103K. The largest seller was Virtu Financial, exiting entirely with an estimated $34K sold.

  • 12 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2017, down from 15 in Q3 2017.
  • Funds reported $607K of Achieve Life Sciences stock for Q4 2017, down 24% quarter-over-quarter.
  • 2 funds opened new Achieve Life Sciences positions in Q4 2017 and 5 closed out, a net change of -3 holders.
  • The largest Achieve Life Sciences buyer in Q4 2017 was Renaissance Technologies, an estimated $103K added.
  • The largest Achieve Life Sciences seller in Q4 2017 was Virtu Financial, an estimated $34K sold.

Based on aggregated 13F filings for Q4 2017.